At 12:23 PM, one million shares changed hands on the BSE at a price of Rs 107 per share. Till 1:30 PM, a total of 5.87 million shares had, together, changed hands on the NSE and BSE
Posts in category Business Standard
TVS Srichakra launches its new Steel Belted Agro Industrial Radial Tyres (06-06-2024)
At trade fair in Cologne
Indices trade with moderate gains; European stocks advance (06-06-2024)
At 13:30 IST, the S&P BSE Sensex was up 499.92 points or 0.67% to 74,882.16. The Nifty 50 index added 151 points or 0.67% to 22,766.70.
Orchid Pharma receives DCGI approval for Enmetazobactam (06-06-2024)
Used in treatment of complicated Urinary Tract Infections
United Breweries Ltd spurts 1.13%, gains for five straight sessions (06-06-2024)
United Breweries Ltd is quoting at Rs 2039.5, up 1.13% on the day as on 12:44 IST on the NSE. The stock is up 35.82% in last one year as compared to a 21.32% gain in NIFTY and a 10.83% gain in the Nifty FMCG.
Procter & Gamble Hygiene and Health Care Ltd soars 0.2%, up for fifth straight session (06-06-2024)
Procter & Gamble Hygiene and Health Care Ltd is quoting at Rs 16533.05, up 0.2% on the day as on 12:44 IST on the NSE. The stock is up 20% in last one year as compared to a 21.32% spurt in NIFTY and a 10.83% spurt in the Nifty FMCG.
SPARC CFO Chetan Rajpara resigns (06-06-2024)
Sun Pharma Advanced Research Company (SPARC) announced that Chetan Rajpara, chief finanacial officer (CFO) of the company has tendered his resignation effective from 5 June 2024.
Rupee trades flat after yesterday’s drubbing (06-06-2024)
Powered by Capital Market – Live News
Orchid Pharma shares rally 6% on DCGI nod for made-in-India antibiotic drug (06-06-2024)
Orchid Pharma has received DCGI’s approval for the manufacturing and marketing its invented, made-in-India Active Pharmaceutical Ingredient (API), Enmetazobactam
Orchid Pharma gains on DCGI nod for new antibiotic drug combination (06-06-2024)
Orchid Pharma rallied 3.92% to Rs 1,037.50 after the company said that it has received an approval from Drugs Controller General of India (DCGI) to manufacture and market its new chemical entity active pharmaceutical ingredient (API), Enmetazobactam.